Blockchain venture builder, advisor and investor, Coinsilium Group, has been appointed by Elevate Health to provide advisory services in relation to its proposed Token Generation Event (TGE).
Elevate Health is developing a platform focused on the behavioural health space, aiming to facilitate a number of cost-reducing reward solutions for healthcare providers, insurers, health authorities, families and employers through a range of technological innovations including mobile apps, wearable devices, smart contracts and reward tokens.
“We have seen several blockchain projects looking to address healthcare related issues, however Elevate’s original approach of tackling health threats and improving lifestyle and health standards on a global scale, combined with the teams highly successful track record, is a clear differentiator for us,” says Coinsilium CEO Eddy Travia.
“We also see significant opportunities for enterprise-level stakeholders, such as insurance companies and healthcare service providers, to enhance their offering by joining the Elevate platform, and we look forward to working closely with this talented team to help them achieve their goals.”
Simon Lewis, Co-founder of Elevate Health, says: “Elevate Health marries blockchain technology with cutting edge behavioral healthcare best practices. These issues are currently very topical which puts us at the vanguard of providing solutions for intransigent health issues. We are very much looking forward to working with Coinsilium who share our enthusiasm and vision and we are confident that, with their high industry profile and reputation, they will provide invaluable support as we build our business.”
Those who enter the market at this time may be surprised to hear that Bitcoin…
George Town, Grand Cayman, 22nd November 2024, Chainwire
Las Vegas, US, 1st November 2024, Chainwire
From digital art to real-estate assets, NFTs have become a significant attraction for investors who…
Singapore, Singapore, 21st October 2024, Chainwire
HO CHI MINH, Vietnam, 17th October 2024, Chainwire